Simulations Plus, Inc.: peers
Simulations Plus, Inc. beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.
Simulations Plus, Inc., Phreesia, Inc., Sharecare, Inc., Health Catalyst, Inc.: the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.
Side by side#
Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.
| Measure | Simulations Plus, Inc.base SLP · 🇺🇸 US Percentile in Healthcare Percentile in USA | Evolent Health, Inc. EVH · 🇺🇸 US Percentile in Healthcare Percentile in USA | American Bitcoin Corp. ABTC · 🇺🇸 US Percentile in Healthcare Percentile in USA | American Well Corporation AMWL · 🇺🇸 US Percentile in Healthcare Percentile in USA | Phreesia, Inc. PHR · 🇺🇸 US Percentile in Healthcare Percentile in USA | Sharecare, Inc. SHCR · 🇺🇸 US Percentile in Healthcare Percentile in USA | OptimizeRx Corporation OPRX · 🇺🇸 US Percentile in Healthcare Percentile in USA | Health Catalyst, Inc. HCAT · 🇺🇸 US Percentile in Healthcare Percentile in USA | Group median |
|---|---|---|---|---|---|---|---|---|---|
| Size | |||||||||
| Market cap (Better neither way: ranked highest first) | $371 Mlast known, Aug 1, 2026 · Market dataLast known value: no current one5th of 8 | $383 MOct 2, 2026 · Market data3rd of 8 | $546 MOct 30, 2026 · Market data2nd of 8 | $233 MOct 27, 2026 · Market data6th of 8 | $759 MAug 1, 2026 · Market data1st of 8 | $374 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one4th of 8 | $165 MOct 20, 2026 · Market data7th of 8 | $139 MAug 1, 2026 · Market data8th of 8 | $373 M8 ranked |
| Revenue (Better neither way: ranked highest first) | $79 MFY2025 · SEC8th of 8 | $1.9 BFY2025 · SEC1st of 8 | $185 MFY2025 · SEC6th of 8 | $249 MFY2025 · SEC5th of 8 | $481 MFY2025 · SEC2nd of 8 | $445 MFY2023 · SEC3rd of 8 | $109 MFY2025 · SEC7th of 8 | $311 MFY2025 · SEC4th of 8 | $280 M8 ranked |
| Net income (Higher is better) | $-65 MFY2025 · SEC3rd of 8 | $-535 MFY2025 · SEC8th of 8 | $-153 MFY2025 · SEC6th of 8 | $-96 MFY2025 · SEC4th of 8 | $2 MFY2025 · SEC2nd of 8 | $-129 MFY2023 · SEC5th of 8 | $5 MFY2025 · SEC1st of 8 | $-178 MFY2025 · SEC7th of 8 | $-112 M8 ranked |
| Employees (Better neither way: ranked highest first) | —— | 3,500As on December 2021 · Profile1st of 6 | —— | 527As on 2021 · Profile5th of 6 | 827As on January 2021 · Profile4th of 6 | 2,400As on 2020 · Profile2nd of 6 | 82As on 2021 · Profile6th of 6 | 1,200As on 2021 · Profile3rd of 6 | 1,0146 ranked |
| Growth | |||||||||
| Market cap change, 30 days (Higher is better) | —— | —— | —— | +0.5%30 days to Oct 27, 2026 · Market dataonly one with it | —— | —— | —— | —— | +0.5%— |
| Revenue growth (Higher is better) | +13.1%FY2025 · SEC4th of 756th68th | -26.6%FY2025 · SEC7th of 79th4th | +158.8%FY2025 · SEC1st of 795th97th | -2.0%FY2025 · SEC6th of 721st24th | +14.5%FY2025 · SEC3rd of 758th71st | ———— | +18.8%FY2025 · SEC2nd of 766th77th | +1.5%FY2025 · SEC5th of 729th33rd | +13.1%7 ranked |
| Revenue growth, 3 years a year (Higher is better) | +13.7%FY2025 · SEC4th of 761st77th | +11.5%FY2025 · SEC5th of 757th73rd | +160.6%FY2025 · SEC1st of 798th99th | -3.5%FY2025 · SEC7th of 719th22nd | +19.6%FY2025 · SEC3rd of 772nd85th | ———— | +20.6%FY2025 · SEC2nd of 773rd86th | +4.0%FY2025 · SEC6th of 739th49th | +13.7%7 ranked |
| Margins and returns | |||||||||
| Gross margin (Higher is better) | 58.4%FY2025 · SEC2nd of 450th72nd | 21.3%FY2025 · SEC4th of 410th22nd | 50.3%FY2025 · SEC3rd of 436th64th | ———— | ———— | ———— | 67.3%FY2025 · SEC1st of 464th80th | ———— | 54.3%4 ranked |
| Operating margin (Higher is better) | -89.3%FY2025 · SEC6th of 725th11th | -21.9%FY2025 · SEC3rd of 740th21st | -123.1%FY2025 · SEC7th of 721st9th | -42.2%FY2025 · SEC4th of 733rd16th | -1.4%FY2025 · SEC2nd of 756th38th | ———— | 10.7%FY2025 · SEC1st of 774th70th | -51.7%FY2025 · SEC5th of 731st15th | -42.2%7 ranked |
| Net margin (Higher is better) | -81.7%FY2025 · SEC6th of 725th11th | -28.5%FY2025 · SEC3rd of 739th19th | -82.7%FY2025 · SEC7th of 725th11th | -38.4%FY2025 · SEC4th of 734th16th | 0.5%FY2025 · SEC2nd of 761st44th | ———— | 4.7%FY2025 · SEC1st of 769th60th | -57.2%FY2025 · SEC5th of 730th14th | -38.4%7 ranked |
| Free cash flow margin (Higher is better) | 22.0%FY2025 · SEC1st of 590th90th | ———— | ———— | -26.5%FY2025 · SEC5th of 534th15th | 14.1%FY2025 · SEC3rd of 579th79th | ———— | 17.1%FY2025 · SEC2nd of 584th84th | -0.1%FY2025 · SEC4th of 552nd34th | 14.1%5 ranked |
| Return on equity (Higher is better) | -42.1%FY2025 · SEC5th of 747th20th | -75.5%FY2025 · SEC7th of 731st13th | -18.2%FY2025 · SEC3rd of 761st29th | -35.4%FY2025 · SEC4th of 751st22nd | 0.8%FY2025 · SEC2nd of 773rd43rd | ———— | 4.2%FY2025 · SEC1st of 775th49th | -58.3%FY2025 · SEC6th of 739th16th | -35.4%7 ranked |
| Return on invested capital (Higher is better) | ———— | ———— | ———— | ———— | ———— | ———— | 6.4%FY2025 · SEConly one with it25th26th | ———— | 6.4%— |
| Valuation | |||||||||
| P/E ratio (Better neither way: ranked highest first) | ———— | ———— | ———— | ———— | 72.6׆price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | ———— | 35.9×price Oct 20, 2026 · Market dataonly one with it57th79th | ———— | 35.9×— |
| Price to sales (Better neither way: ranked highest first) | ———— | 0.2×price Oct 2, 2026 · Market data4th of 41st4th | 2.0×price Oct 30, 2026 · Market data1st of 433rd48th | 1.1×price Oct 27, 2026 · Market data3rd of 419th32nd | 1.5׆price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | ———— | 1.7×price Oct 20, 2026 · Market data2nd of 429th43rd | 0.5׆price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | 1.4×4 ranked |
| Price to book (Better neither way: ranked highest first) | ———— | 0.9×price Oct 2, 2026 · Market data3rd of 418th18th | 0.8×price Oct 30, 2026 · Market data4th of 415th15th | 1.0×price Oct 27, 2026 · Market data2nd of 419th20th | 2.3׆price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | ———— | 1.3×price Oct 20, 2026 · Market data1st of 425th30th | 0.6׆price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | 1.0×4 ranked |
| Free cash flow yield (Higher is better) | ———— | -20.4%price Oct 2, 2026 · Market data3rd of 433rd14th | -11.1%price Oct 30, 2026 · Market data2nd of 441st20th | -28.3%price Oct 27, 2026 · Market data4th of 427th12th | 8.9%†price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | ———— | 11.3%price Oct 20, 2026 · Market data1st of 495th89th | -0.2%†price Aug 1, 2026 · Market datanot ranked: old priceold priceold price | -15.7%4 ranked |
| Financial strength | |||||||||
| Debt to equity (Lower is better) | ———— | 2.3×FY2025 · SEC4th of 490th88th | ———— | ———— | 0.0×FY2025 · SEC1st of 410th7th | ———— | 0.2×FY2025 · SEC2nd of 432nd23rd | 0.6×FY2025 · SEC3rd of 461st51st | 0.4×4 ranked |
| Net debt to EBITDA (Lower is better) | ———— | ———— | ———— | ———— | -2.9×FY2025 · SEC1st of 26th3rd | ———— | 0.2×FY2025 · SEC2nd of 230th21st | ———— | -1.3×2 ranked |
| Piotroski F-score (Higher is better) | —— | 5 of 9FY2025 · SEC2nd of 2 | —— | —— | —— | —— | 8 of 9FY2025 · SEC1st of 2 | —— | 6.5 of 92 ranked |
| Scorecard | |||||||||
| Scorecard (Higher is better) | 7 of 15FY2025 · Scorecard3rd of 7 | 8 of 22FY2025 · Scorecard4th of 7 | 7 of 20FY2025 · Scorecard5th of 7 | 5 of 20FY2025 · Scorecard6th of 7 | 12 of 17FY2025 · Scorecard1st of 7 | —— | 16 of 24FY2025 · Scorecard2nd of 7 | 4 of 17FY2025 · Scorecard7th of 7 | 36% passed7 ranked |
| Valuation checks (Higher is better) | —— | 2 of 5FY2025 · Scorecard2nd of 4 | 1 of 5FY2025 · Scorecard4th of 4 | 2 of 5FY2025 · Scorecard2nd of 4 | —— | —— | 3 of 6FY2025 · Scorecard1st of 4 | —— | 40% passed4 ranked |
| Growth checks (Higher is better) | 4 of 6FY2025 · Scorecard3rd of 7 | 2 of 6FY2025 · Scorecard5th of 7 | 4 of 6FY2025 · Scorecard3rd of 7 | 1 of 6FY2025 · Scorecard7th of 7 | 6 of 6FY2025 · Scorecard1st of 7 | —— | 6 of 6FY2025 · Scorecard1st of 7 | 2 of 6FY2025 · Scorecard5th of 7 | 67% passed7 ranked |
| Profitability checks (Higher is better) | 0 of 5FY2025 · Scorecard5th of 7 | 0 of 5FY2025 · Scorecard5th of 7 | 1 of 5FY2025 · Scorecard3rd of 7 | 1 of 5FY2025 · Scorecard3rd of 7 | 3 of 5FY2025 · Scorecard1st of 7 | —— | 3 of 6FY2025 · Scorecard2nd of 7 | 0 of 5FY2025 · Scorecard5th of 7 | 20% passed7 ranked |
| Financial health checks (Higher is better) | 2 of 2FY2025 · Scorecard1st of 7 | 2 of 4FY2025 · Scorecard4th of 7 | 0 of 3FY2025 · Scorecard7th of 7 | 1 of 3FY2025 · Scorecard6th of 7 | 3 of 5FY2025 · Scorecard3rd of 7 | —— | 4 of 5FY2025 · Scorecard2nd of 7 | 2 of 4FY2025 · Scorecard4th of 7 | 50% passed7 ranked |
| Shareholder returns checks (Higher is better) | 1 of 2FY2025 · Scorecard3rd of 7 | 2 of 2FY2025 · Scorecard1st of 7 | 1 of 1FY2025 · Scorecard1st of 7 | 0 of 1FY2025 · Scorecard4th of 7 | 0 of 1FY2025 · Scorecard4th of 7 | —— | 0 of 1FY2025 · Scorecard4th of 7 | 0 of 2FY2025 · Scorecard4th of 7 | 0% passed7 ranked |
| Ownership | |||||||||
| Held by institutions (Better neither way: ranked highest first) | 84.5%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 7 | 92.6%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 7 | 7.5%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in7th of 7 | 47.0%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in6th of 7 | 92.9%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 7 | —— | 64.9%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in5th of 7 | 66.2%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 7 | 66.2%7 ranked |
| Institutions holding (Better neither way: ranked highest first) | 1562026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 7 | 1932026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 7 | 912026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in6th of 7 | 672026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in7th of 7 | 2302026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 7 | —— | 1032026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in5th of 7 | 1092026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 7 | 1097 ranked |
| Institutional holding, change over the quarter (Better neither way: ranked highest first) | +3.7 pp2026-Q2 against 2026-Q1 · 13F1st of 5 | +1.1 pp2026-Q2 against 2026-Q1 · 13F2nd of 5 | —— | —— | -2.2 pp2026-Q2 against 2026-Q1 · 13F3rd of 5 | —— | -13.0 pp2026-Q2 against 2026-Q1 · 13F5th of 5 | -6.4 pp2026-Q2 against 2026-Q1 · 13F4th of 5 | -2.2 pp5 ranked |
| Dividends | |||||||||
| Shareholder yield (Higher is better) | ———— | 10.4%FY2025 · SEConly one with it92nd89th | ———— | ———— | ———— | ———— | ———— | 3.6%†FY2025 · SECnot ranked: old priceold priceold price | 10.4%— |
Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).
† The market cap behind this figure is more than 60 days old (no market-data feed for that exchange yet): it is shown but not ranked or given a percentile.
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Simulations Plus, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Evolent Health, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; American Bitcoin Corp.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; American Well Corporation: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Phreesia, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Sharecare, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; OptimizeRx Corporation: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Health Catalyst, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover.
Where each stands in its sector and country: Operating margin#
The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.
| Company | Operating margin | In its sector | In its country |
|---|---|---|---|
| Simulations Plus, Inc. | -89.3%FY2025 | 25th percentile in Healthcaremedian -7.7%, 674 companies | 11th percentile in USAmedian 3.5%, 2,594 companies |
| Evolent Health, Inc. | -21.9%FY2025 | 40th percentile in Healthcaremedian -7.7%, 674 companies | 21st percentile in USAmedian 3.5%, 2,594 companies |
| American Bitcoin Corp. | -123.1%FY2025 | 21st percentile in Healthcaremedian -7.7%, 674 companies | 9th percentile in USAmedian 3.5%, 2,594 companies |
| American Well Corporation | -42.2%FY2025 | 33rd percentile in Healthcaremedian -7.7%, 674 companies | 16th percentile in USAmedian 3.5%, 2,594 companies |
| Phreesia, Inc. | -1.4%FY2025 | 56th percentile in Healthcaremedian -7.7%, 674 companies | 38th percentile in USAmedian 3.5%, 2,594 companies |
| Sharecare, Inc. | — | — | — |
| OptimizeRx Corporation | 10.7%FY2025 | 74th percentile in Healthcaremedian -7.7%, 674 companies | 70th percentile in USAmedian 3.5%, 2,594 companies |
| Health Catalyst, Inc. | -51.7%FY2025 | 31st percentile in Healthcaremedian -7.7%, 674 companies | 15th percentile in USAmedian 3.5%, 2,594 companies |
Revenue by fiscal year, and the rank in the group#
Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).
Revenue
Rank in the group
| Fiscal year | Simulations Plus, Inc. | Evolent Health, Inc. | American Bitcoin Corp. | American Well Corporation | Phreesia, Inc. | Sharecare, Inc. | OptimizeRx Corporation | Health Catalyst, Inc. |
|---|---|---|---|---|---|---|---|---|
| 2025 | $79 MSEC7th | $1.9 BSEC1st | $185 MSEC5th | $249 MSEC4th | $481 MSEC2nd | — | $109 MSEC6th | $311 MSEC3rd |
| 2024 | $70 MSEC7th | $2.6 BSEC1st | $72 MSEC6th | $254 MSEC4th | $420 MSEC2nd | — | $92 MSEC5th | $307 MSEC3rd |
| 2023 | $60 MSEC8th | $2.0 BSEC1st | $65 MSEC7th | $259 MSEC5th | $356 MSEC3rd | $445 MSEC2nd | $72 MSEC6th | $296 MSEC4th |
| 2022 | $54 MSEC7th | $1.4 BSEC1st | $10 MSEC8th | $277 MSEC4th | $281 MSEC3rd | $442 MSEC2nd | $62 MSEC6th | $276 MSEC5th |
| 2021 | $46 MSEC7th | $908 MSEC1st | $18 MSEC8th | $253 MSEC3rd | $213 MSEC5th | $413 MSEC2nd | $61 MSEC6th | $242 MSEC4th |
| 2020 | $42 MSEC7th | $925 MSEC1st | $13 MSEC8th | $245 MSEC3rd | $149 MSEC5th | $329 MSEC2nd | $43 MSEC6th | $189 MSEC4th |
| 2019 | $34 MSEC6th | $687 MSEC1st | $11 MSEC8th | $149 MSEC4th | $125 MSEC5th | $340 MSEC2nd | $25 MSEC7th | $155 MSEC3rd |
| 2018 | $30 MSEC5th | $627 MSEC1st | $10 MSEC7th | $114 MSEC2nd | $100 MSEC4th | — | $21 MSEC6th | $113 MSEC3rd |
| 2017 | $24 MSEC4th | $435 MSEC1st | — | — | $80 MSEC2nd | — | $12 MSEC5th | $73 MSEC3rd |
| 2016 | $20 MSEC2nd | $254 MSEC1st | — | — | — | — | $8 MSEC3rd | — |
| 2015 | $18 MSEC2nd | $97 MSEC1st | — | — | — | — | $7 MSEC3rd | — |
| 2014 | $11 MSEC1st | — | — | — | — | — | $7 MSEC2nd | — |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.
Suggested peers of Simulations Plus, Inc.#
Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.
- Evolent Health, Inc.EVH · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $383 M market cap against $371 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $383 M (Oct 2, 2026) · revenue $1.9 B (year to December 2025)100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)In the group
- American Bitcoin Corp.ABTC · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $546 M market cap against $371 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $546 M (Oct 30, 2026) · revenue $185 M (year to December 2025)98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)In the group
- American Well CorporationAMWL · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $233 M market cap against $371 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $233 M (Oct 27, 2026) · revenue $249 M (year to December 2025)97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)In the group
- Phreesia, Inc.PHR · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $759 M market cap against $371 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $759 M (Aug 1, 2026) · revenue $481 M (year to January 2026)95 of 100 (industry or sector 50 + size 25 + country 15 + figures on file 5)In the group
- Sharecare, Inc.SHCR · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $374 M market cap against $371 M · Same country: USAMarket cap $374 M (last known, Jan 5, 2024) · revenue $445 M (year to December 2023)95 of 100 (industry or sector 50 + size 30 + country 15)In the group
- OptimizeRx CorporationOPRX · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $165 M market cap against $371 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $165 M (Oct 20, 2026) · revenue $109 M (year to December 2025)95 of 100 (industry or sector 50 + size 25 + country 15 + figures on file 5)In the group
- Health Catalyst, Inc.HCAT · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $139 M market cap against $371 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $139 M (Aug 1, 2026) · revenue $311 M (year to December 2025)94 of 100 (industry or sector 50 + size 24 + country 15 + figures on file 5)In the group
- HealthStream, Inc.HSTM · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $1.0 B market cap against $371 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $1.0 B (Oct 14, 2026) · revenue $304 M (year to December 2025)93 of 100 (industry or sector 50 + size 23 + country 15 + figures on file 5)+ Add
- Augmedix, Inc.AUGX · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $278 M market cap against $371 M · Same country: USAMarket cap $278 M (last known, Jan 5, 2024)93 of 100 (industry or sector 50 + size 28 + country 15)+ Add
- GoodRxGDRX · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $1.2 B market cap against $371 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $1.2 B (Oct 14, 2026) · revenue $797 M (year to December 2025)92 of 100 (industry or sector 50 + size 23 + country 15 + figures on file 5)+ Add
- Convey Holding Parent Inc.CNVY · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $554 M market cap against $371 M · Same country: USAMarket cap $554 M (last known, Jan 7, 2022) · revenue $337 M (year to December 2021)92 of 100 (industry or sector 50 + size 27 + country 15)+ Add
- HealthLynked Corp.HLYK · 🇺🇸 USASame industry: Healthcare Information Services · Similar size: $112 M market cap against $371 M · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $112 M (last known, Jan 7, 2022) · revenue $2 M (year to December 2025)92 of 100 (industry or sector 50 + size 22 + country 15 + figures on file 5)+ Add
Any figure over the years, other peers or a saved group: open this group in the peer workspace.